F.D.A. authorizes another antibody treatment for high-risk Covid patients.
By BY REBECCA ROBBINS
Business
https://ift.tt/3yFK0IV
The drug, from GlaxoSmithKline and Vir, aims to keep Covid patients out of the hospital.
New York Times
Drugs (Pharmaceuticals), Antibodies, Coronavirus (2019-nCoV)
May 27, 2021 at 01:22AM